eMed Collaborates with Aon for Health Benefits Innovation
eMed®, a prominent name in Population Health technology and digital healthcare management, has initiated a groundbreaking collaboration with Aon, a leading global professional services firm. This partnership aims to enhance obesity management services for employees across the United States.
Enhancing Employee Health Through Technology
The partnership introduces a unique digital GLP-1 benefit program, offering virtual clinical support. This innovative approach utilizes data-driven methodologies to improve adherence to obesity management strategies, helping employees achieve better health outcomes. By merging resources and expertise, eMed and Aon strive to address critical issues surrounding obesity, diabetes, and related health concerns.
Positive Impacts on Healthcare Costs
The collaboration is particularly significant, given Aon's recent findings that indicate substantial cost-effective benefits derived from GLP-1 therapy. The data shows impressive outcomes, including a seven percentage point reduction in the growth of medical spending in the second year of therapy and a 44 percent decrease in the risk of hospitalizations due to major adverse cardiovascular events. These statistics underscore the potential of GLP-1 treatments when paired with robust support systems.
Leader in Digital Health Solutions
Dr. Patrice Harris, the CEO of eMed, expressed enthusiasm for the collaboration, emphasizing the commitment to improving employee health through accessible and effective healthcare solutions. She underlined that eMed’s platform is scientifically validated, delivering positive health outcomes for users while also assisting employers in managing their costs effectively. The goal is not simply to offer medication but to ensure its effective use — a mission aligned with Aon's research and findings.
Holistic Health and Wellness Approach
Lisa Stevens, Aon's Chief Administration Officer, highlighted the importance of holistic support, including nutrition, exercise, and mental health resources. She noted that this comprehensive support can enable lasting health improvements, reiterating that accessibility and affordability of GLP-1 medications can be achieved without compromising dignity. Both organizations are paving the way for a new standard in employee health benefits.
Commitment to Population Health
eMed's dedication extends beyond just offering digital tools; it empowers individuals to confront pressing health issues such as obesity and its associated comorbidities. As the indications for GLP-1 medications expand, making informed, data-driven choices will be essential in managing rising healthcare costs while actively improving health outcomes.
Addressing Obesity at a Macro Level
Dr. Michael Mina, eMed's Chief Science Officer, shared insights on the broader implications of this partnership. He noted that addressing obesity through health equity and access could create far-reaching positive economic impacts. Employers have historically supported wellness, yet many initiatives have not significantly altered population health. This collaboration aims to change that narrative.
About eMed
eMed® stands at the forefront of delivering Population Health solutions, focusing on GLP-1/GIP programs and chronic care management. Their innovative technology, Empathetic AI™, makes healthcare more accessible and effective for employees, featuring programs designed to maintain health and wellness while closely managing costs for employers. With a growing global clientele, eMed is committed to transforming employer-sponsored health benefit programs with a comprehensive approach.
Frequently Asked Questions
What is the purpose of the eMed and Aon collaboration?
The collaboration aims to enhance obesity management services for Aon's employees through a digital GLP-1 benefit program and virtual clinical support.
How does the GLP-1 benefit program work?
The program provides employees with access to GLP-1 medications along with support resources such as nutrition and mental health services to improve adherence to treatment.
What are the expected health outcomes of this partnership?
The partnership seeks to achieve better health outcomes, including reduced medical spending and decreased risks of serious cardiovascular events.
What technology does eMed use for its programs?
eMed utilizes Empathetic AI™ technology to create effective chronic care management and GLP-1 benefit programs tailored to employees' needs.
What role do employers play in this initiative?
Employers play a crucial role by adopting these health benefit programs, which can lead to improved employee health and lowered healthcare costs, ultimately benefiting both employees and employers.
